Bicycle Therapeutics ($BCYC) Insider Trading & Smart Money Activity
Bicycle Therapeutics plc ($BCYC) has 11 insider trades and 2 13F position changes on file. In the last 12 months on the open market, no insider bought and 6 insiders sold ($62.70K), net -$62.70K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 6
- Net insider $ (12 mo)
- -$62.70K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 0
BCYC insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 2 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 11 · $62.70K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All BCYC insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Thompson Travis AlvinChief Financial Officer | Sell (Open-market sale) | 79 sh | $282.03 | — | ||||||
| Insider | Skynner MichaelCHIEF SCIENTIFIC OFFICER | Sell (Open-market sale) | 503 sh | $1.80K | — | ||||||
| Insider | Perry Jennifer ScottChief Operating Officer | Sell (Open-market sale) 10b5-1 | 406 sh | $1.52K | — | ||||||
| Insider | Lee KevinCHIEF EXECUTIVE OFFICER | Sell (Open-market sale) | 1.64K sh | $5.85K | — | ||||||
| Insider | Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF | Sell (Open-market sale) | 242 sh | $863.94 | — | ||||||
| Insider | Thompson Travis AlvinChief Financial Officer | Sell (Open-market sale) | 893 sh | $3.10K | — | ||||||
| Insider | Swanton Robert CharlesDirector | Sell (Open-market sale) | 3.43K sh | $11.91K | — | ||||||
| Insider | Skynner MichaelCHIEF SCIENTIFIC OFFICER | Sell (Open-market sale) | 1.94K sh | $6.74K | — | ||||||
| Insider | Perry Jennifer ScottChief Operating Officer | Sell (Open-market sale) 10b5-1 | 1.09K sh | $3.80K | — | ||||||
| Insider | Lee KevinCHIEF EXECUTIVE OFFICER | Sell (Open-market sale) | 6.17K sh | $21.40K | — | ||||||
| Insider | Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF | Sell (Open-market sale) | 1.57K sh | $5.45K | — | ||||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -30K sh | — | |||||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -30K sh | — |
1W / 1M / 6M = how BCYC moved from the trade or filing date.
Insider trading in BCYC: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Thompson Travis Alvin | Chief Financial Officer | 2 | -$3.38K | Oct 5, 2026 | |
| Skynner Michael | CHIEF SCIENTIFIC OFFICER | 2 | -$8.53K | Oct 5, 2026 | |
| Perry Jennifer Scott | Chief Operating Officer | 2 | -$5.31K | Oct 5, 2026 | |
| Lee Kevin | CHIEF EXECUTIVE OFFICER | 2 | -$27.25K | Oct 5, 2026 | |
| Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | 2 | -$6.32K | Oct 5, 2026 | |
| Swanton Robert Charles | Director | 1 | -$11.91K | Oct 2, 2026 |
Institutions moving BCYC (13F)
Frequently asked questions
Are BCYC insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 6 insiders made 11 open-market sales worth $62.70K, a net -$62.70K.
What is the latest insider trade in BCYC?
Thompson Travis Alvin, Chief Financial Officer filed a sell (open-market sale) of 79 sh worth $282.03 on Oct 5, 2026.
Which institutions changed their BCYC positions?
Recent 13F filers moving the stock include Dekabank Deutsche Girozentrale.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.